Benitec Biopharma Inc.
Benitec Biopharma Inc.
Benitec Biopharma Inc. (BNTC) — SEC Financial Statements & Analysis
Benitec Biopharma Inc. (BNTC) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 185 | 189 | 94 | 98 | 104 | 78 | 68 | 51 | - | 20 | 26 | 2 | |||||
Due From Banks | - | - | - | - | - | - | - | 51 | 14 | - | - | 2 | |||||
Restricted Cash Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts And Other Receivables Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | |||||
Assets Current | 186 | 190 | 95 | 99 | 104 | 79 | 68 | 52 | 14 | 21 | 26 | 4 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deposit Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Assets | 187 | 191 | 96 | 100 | 105 | 79 | 69 | 52 | 15 | 21 | 27 | 4 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable And Other Accrued Liabilities Cur… | 2 | 2 | 1 | 1 | 6 | 2 | 4 | 4 | 3 | 5 | 4 | 3 | |||||
Employee Related Liabilities Current | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 3 | 3 | 2 | 2 | 7 | 3 | 5 | 5 | 3 | 6 | 5 | 4 | |||||
Operating Lease Liability Noncurrent | 0 | 1 | 0 | 0 | 1 | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 4 | 3 | 2 | 2 | 8 | 3 | 5 | 5 | 3 | 6 | 5 | 4 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 445 | 437 | 331 | 326 | 310 | 279 | 260 | 238 | 197 | 197 | 197 | 169 | |||||
Retained Earnings Accumulated Deficit | -261 | -249 | -237 | -228 | -212 | -203 | -195 | -190 | -185 | -181 | -174 | -168 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |||||
Stockholders Equity | 183 | 187 | 94 | 97 | 98 | 76 | 64 | 47 | 12 | 15 | 22 | 0 | |||||
Liabilities And Stockholders Equity | 187 | 191 | 96 | 100 | 105 | 79 | 69 | 52 | 15 | 21 | 27 | 4 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 480 | 480 | 480 | 480 | 480 | 480 | 480 | 480 | 480 | 480 | 480 | 480 | |||||
Common Stock Shares Issued | 34 | 34 | 26 | 26 | 26 | 23 | 36 | 30 | 27 | 26 | 25 | 30 | |||||
Shares Outstanding | 34 | 34 | 26 | 26 | 26 | 23 | 18 | 20 | 22 | 21 | 20 | 30 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | - | 5 | - | - | - | - | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.19% | -4.37% | -7.45% | 0.00% | -3.70% | 5.38% | -10.97% | 11.56% | - | - | - | - |
| 2025 | 7.98% | 16.35% | 10.48% | 15.47% | 9.51% | 33.78% | 17.82% | -3.02% | -19.29% | 15.84% | -2.59% | -11.32% |
| 2024 | -5.49% | -5.49% | -18.64% | 71.52% | 95.37% | 213.92% | -8.62% | 14.41% | -1.35% | 30.60% | 21.50% | 33.90% |
| 2023 | - | - | - | - | - | - | 8.88% | 14.95% | -39.53% | 15.59% | 15.93% | 10.85% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 56.82 | 67.69 | 46.95 | 54.67 | 14.80 | 25.48 | 15.01 | 10.49 | 4.18 | 3.62 | 5.83 | 0.94 | |||||
| Quick Ratio | 56.47 | 67.49 | 46.72 | 54.32 | 14.75 | 25.36 | 14.92 | 10.39 | 4.13 | 3.56 | 5.72 | 0.64 | |||||
| Working Capital | 182.74M | 186.79M | 93.05M | 96.72M | 96.98M | 75.62M | 63.78M | 46.75M | 10.93M | 15.05M | 21.88M | -249.00K | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.02 | 0.02 | 0.03 | 0.02 | 0.08 | 0.04 | 0.07 | 0.11 | 0.30 | 0.38 | 0.21 | 21.10 | |||||
| Interest Coverage TTM | -9.26 | -11.35 | -12.40 | -12.71 | -11.82 | -11.18 | -14.61 | -24.03 | -895.50 | -803.41 | -679.17 | -578.21 | |||||
| Debt Ratio | 0.02 | 0.02 | 0.03 | 0.02 | 0.07 | 0.04 | 0.07 | 0.10 | 0.23 | 0.28 | 0.18 | 0.95 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.84 | -0.96 | -1.01 | -1.05 | -0.88 | -0.63 | -0.75 | -1.18 | -1.19 | -1.21 | -1.35 | -2.02 | |||||
| Free Cash Flow Per Share TTM | -0.40 | -0.40 | -0.54 | -0.65 | -0.48 | -0.59 | -0.70 | -1.07 | -1.12 | -1.00 | -1.23 | -1.86 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | - | - | - | - | - | - | - | - | -307,028.57% | -35,560.66% | -27,166.67% | -25,441.33% | |||||
| Net Profit Margin TTM | - | - | - | - | - | - | - | - | -309,885.71% | -35,754.10% | -27,230.67% | -26,082.67% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | - | - | - | - | -100.00% | -100.00% | -100.00% | -100.00% | -89.71% | -1.61% | 2.74% | 2.74% | |||||
| Net Income Growth (1Y) | 22.79% | 86.82% | 100.53% | 74.32% | 55.97% | 8.25% | 2.12% | 11.19% | 8.63% | 15.73% | 11.87% | 7.44% | |||||
| EPS Growth (1Y) | -4.03% | 51.40% | 34.67% | -11.59% | -26.13% | -47.60% | -44.70% | -41.27% | -31.54% | -27.17% | -0.65% | 11.80% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -12.66 | -14.04 | -13.93 | -11.17 | -14.84 | -19.93 | -12.29 | -5.90 | -4.42 | -2.67 | -2.23 | -2.01 | |||||
| P/B | 2.87 | 3.30 | 6.22 | 4.35 | 5.15 | 6.20 | 3.99 | 2.72 | 8.35 | 3.77 | 2.05 | 195.12 | |||||
| P/S TTM | - | - | - | - | - | - | - | - | 13,711.42 | 954.94 | 608.41 | 525.52 | |||||
| Market Cap | 525.96M | 619.22M | 582.54M | 423.65M | 502.18M | 470.53M | 256.25M | 128.37M | 95.98M | 58.25M | 45.63M | 39.41M | |||||
| Enterprise Value | 341.09M | 430.32M | 487.95M | 325.79M | 398.73M | 392.18M | 188.35M | 137.92M | 81.82M | 37.86M | 19.75M | 36.92M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -19.82M | -18.44M | -22.37M | -23.61M | -18.69M | -21.94M | -19.59M | -19.58M | -20.39M | -18.07M | -18.55M | -18.01M | |||||
| Net Debt | -184.88M | -188.90M | -94.59M | -97.86M | -103.45M | -78.35M | -67.91M | 9.56M | -14.16M | -20.39M | -25.88M | -2.49M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data